Standardized uptake decrease on [18F]-fluorodeoxyglucose positron emission tomography after neoadjuvant chemotherapy is a prognostic classifier for long-term outcome after multimodality treatment: secondary analysis of a randomized trial for resectable stage IIIA/B non-small-cell lung cancer

Poettgen, Christoph; Gauler, Thomas; Bellendorf, Alexander; Guberina, Maja; Bockisch, Andreas; Schwenzer, Nina; Heinzelmann, Frank; Cordes, Sebastian; Schuler, Martin H.; Welter, Stefan; Stamatis, Georgios; Friedel, Godehard; Darwiche, Kaid; Joeckel, Karl-Heinz; Eberhardt, Wilfried; Stuschke, Martin

Standardized uptake decrease on [18F]-fluorodeoxyglucose positron emission tomography after neoadjuvant chemotherapy is a prognostic classifier for long-term outcome after multimodality treatment: secondary analysis of a randomized trial for resectable stage IIIA/B non-small-cell lung cancer

Autor(en):

Poettgen, Christoph; Gauler, Thomas; Bellendorf, Alexander; Guberina, Maja; Bockisch, Andreas; Schwenzer, Nina; Heinzelmann, Frank; Cordes, Sebastian; Schuler, Martin H.; Welter, Stefan; Stamatis, Georgios; Friedel, Godehard; Darwiche, Kaid; Joeckel, Karl-Heinz; Eberhardt, Wilfried; Stuschke, Martin

Tübinger Autor(en):

Schwenzer, Nina
Heinzelmann, Frank Michael

Erschienen in:

Journal of Clinical Oncology (2016), Bd. 34, H. 21, S. 2526-2533

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2015.65.5167

ISSN:

1527-7755